171 related articles for article (PubMed ID: 31925925)
1. Sirolimus for the treatment of juvenile nasopharyngeal angiofibroma.
Fernández KS; de Alarcon A; Adams DM; Hammill AM
Pediatr Blood Cancer; 2020 Apr; 67(4):e28162. PubMed ID: 31925925
[TBL] [Abstract][Full Text] [Related]
2. Spontaneous Involution of Juvenile Nasopharyngeal Angiofibromas: Report of a Case.
Chua JT; Choy JA; Sahyouni R; Birkenbeuel JL; Cheung DC; Kuan EC; Bhandarkar ND
Laryngoscope; 2021 Jul; 131(7):1455-1457. PubMed ID: 33174222
[TBL] [Abstract][Full Text] [Related]
3. [Facial angiofibromas associated to tuberous sclerosis treated with topical sirolimus].
Tiedemann Svendsen M; Bygum A; Hansen LK; Broesby-Olsen S
Ugeskr Laeger; 2013 Oct; 175(43):2569-70. PubMed ID: 24629155
[TBL] [Abstract][Full Text] [Related]
4. [Nasopharyngeal angiofibroma with intracranial extension: situating the chemotherapy-radiotherapy association].
Belcadhi M; Mani R; Harzallah M; Bouaouina N; Bouzouita K
Cancer Radiother; 2008 Sep; 12(5):385-8. PubMed ID: 18339570
[TBL] [Abstract][Full Text] [Related]
5. Preoperative Embolization to Improve the Surgical Management and Outcome of Juvenile Nasopharyngeal Angiofibroma (JNA) in a Single Center: 10-Year Experience.
Lutz J; Holtmannspötter M; Flatz W; Meier-Bender A; Berghaus A; Brückmann H; Zengel P
Clin Neuroradiol; 2016 Dec; 26(4):405-413. PubMed ID: 25630469
[TBL] [Abstract][Full Text] [Related]
6. A rare complication of embolization in juvenile nasopharyngeal angiofibroma.
Onerci M; Gumus K; Cil B; Eldem B
Int J Pediatr Otorhinolaryngol; 2005 Mar; 69(3):423-8. PubMed ID: 15733605
[TBL] [Abstract][Full Text] [Related]
7. Juvenile nasopharyngeal angiofibroma.
Zito J; Fitzpatrick P; Amedee R
J La State Med Soc; 2001 Aug; 153(8):395-8. PubMed ID: 11565634
[TBL] [Abstract][Full Text] [Related]
8. Juvenile nasopharyngeal angiofibroma.
Blount A; Riley KO; Woodworth BA
Otolaryngol Clin North Am; 2011 Aug; 44(4):989-1004, ix. PubMed ID: 21819885
[TBL] [Abstract][Full Text] [Related]
9. [Juvenile nasopharyngeal angiofibroma].
Padilla Parrado M; Díaz Sastre MA; Jiménez Antolín JA; Caro García MA
An Otorrinolaringol Ibero Am; 2005; 32(4):361-71. PubMed ID: 16156366
[TBL] [Abstract][Full Text] [Related]
10. Juvenile nasopharyngeal angiofibroma in prepubertal males: A diagnostic dilemma.
Camilon PR; Rahbar R; Cunningham MJ; Adil EA
Laryngoscope; 2019 Aug; 129(8):1777-1783. PubMed ID: 30569464
[TBL] [Abstract][Full Text] [Related]
11. Wnt pathway, angiogenetic and hormonal markers in sporadic and familial adenomatous polyposis-associated juvenile nasopharyngeal angiofibromas (JNA).
Ponti G; Losi L; Pellacani G; Rossi GB; Presutti L; Mattioli F; Villari D; Wannesson L; Alicandri Ciufelli M; Izzo P; De Rosa M; Marone P; Seidenari S
Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):173-8. PubMed ID: 18227724
[TBL] [Abstract][Full Text] [Related]
12. Advanced craniofacial juvenile nasopharyngeal angiofibroma. Description of surgical series, case report, and review of literature.
Cherekaev VA; Golbin DA; Kapitanov DN; Roginsky VV; Yakovlev SB; Arustamian SR
Acta Neurochir (Wien); 2011 Mar; 153(3):499-508. PubMed ID: 21274578
[TBL] [Abstract][Full Text] [Related]
13. [Chemotherapy of juvenile angiofibroma--an alternative?].
Schick B; Kahle G; Hässler R; Draf W
HNO; 1996 Mar; 44(3):148-52. PubMed ID: 8641902
[TBL] [Abstract][Full Text] [Related]
14. [Juvenile nasopharyngeal angiofibroma: endoscopic surgery and follow-up results].
Zhou B; Cai T; Huang Q; Liang XH; Ni X; Wei YX; Cui SJ; Zhang L; Wang T; Liu HC; Liu M; Han DM
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Mar; 45(3):180-5. PubMed ID: 20450693
[TBL] [Abstract][Full Text] [Related]
15. The risk factors for residual juvenile nasopharyngeal angiofibroma and the usual residual sites.
Liu Z; Hua W; Zhang H; Wang J; Song X; Hu L; Lu H; Wang D
Am J Otolaryngol; 2019; 40(3):343-346. PubMed ID: 30885446
[TBL] [Abstract][Full Text] [Related]
16. Differential Gene Expression and Pathway Analysis in Juvenile Nasopharyngeal Angiofibroma Using RNA Sequencing.
Jones JW; Usman S; New J; Holcomb A; Gunewardena S; Tawfik O; Hoover L; Bruegger D; Thomas SM
Otolaryngol Head Neck Surg; 2018 Sep; 159(3):572-575. PubMed ID: 29634432
[TBL] [Abstract][Full Text] [Related]
17. The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis.
Hofbauer GF; Marcollo-Pini A; Corsenca A; Kistler AD; French LE; Wüthrich RP; Serra AL
Br J Dermatol; 2008 Aug; 159(2):473-5. PubMed ID: 18547304
[TBL] [Abstract][Full Text] [Related]
18. Definitive radiotherapy for juvenile nasopharyngeal angiofibroma.
McAfee WJ; Morris CG; Amdur RJ; Werning JW; Mendenhall WM
Am J Clin Oncol; 2006 Apr; 29(2):168-70. PubMed ID: 16601437
[TBL] [Abstract][Full Text] [Related]
19. The use of flutamide for the neoadjuvant treatment of juvenile nasopharyngeal angiofibroma: a review of the literature comparing results by pubertal status and tumor stage.
Sitenga G; Granger P; Hepola K; Aird J; Silberstein PT
Int J Dermatol; 2022 Nov; 61(11):1346-1352. PubMed ID: 34748211
[TBL] [Abstract][Full Text] [Related]
20. Endoscopic skull base techniques for juvenile nasopharyngeal angiofibroma.
Zanation AM; Mitchell CA; Rose AS
Otolaryngol Clin North Am; 2012 Jun; 45(3):711-30, ix. PubMed ID: 22588045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
